Showing results (181-190 of 319) with videos related to
Sort By:
Pageof 32
Statistics in Medicine|October 1, 2008
Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infectionOliver Bembom, Maya L Petersen, Soo-Yon Rhee, et al.Transfusion|September 1, 1994
Direct oral questions to blood donors: the impact on screening for human immunodeficiency virusE S Johnson, L S Doll, G A Satten, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assaysNancy S Shulman, Jamael Delgado, Ronald J Bosch, et al.AIDS Research and Human Retroviruses|January 7, 2003
HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapyRami Kantor, Lynn S Zijenah, Robert W Shafer, et al.Nature Reviews. Genetics|September 18, 2021
The biological and clinical significance of emerging SARS-CoV-2 variantsKaiming Tao, Philip L Tzou, Janin Nouhin, et al.Bioinformatics (Oxford, England)|October 13, 2010
A classification model for G-to-A hypermutation in hepatitis B virus ultra-deep pyrosequencing readsElizabeth C Reuman, Severine Margeridon-Thermet, Harrison B Caudill, et al.Open Forum Infectious Diseases|May 2, 2019
National and International Dimensions of Human Immunodeficiency Virus-1 Sequence Clusters in a Northern California Clinical CohortSoo-Yon Rhee, Brittany R Magalis, Leo Hurley, et al.The Journal of Clinical Investigation|November 20, 1998
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitorsM A Winters, K L Coolley, Y A Girard, et al.The New England Journal of Medicine|April 22, 1993
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infectionP M Small, R W Shafer, P C Hopewell, et al.Antiviral Research|October 18, 2011
The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatmentW Jeffrey Fessel, Brooke Anderson, Stephen E Follansbee, et al.Pageof 32